Blog2021-08-30T10:42:30-07:00

Blog

AIMS Institute v DEA – Right To Try Update – DEA Issues Final Action Letter

Well, the long-awaited final action letter from DEA has arrived.    AIMS Institute is now clear to pursue its claims against DEA to stop DEA from interdicting use of Phase II experimental psilocybin compounds on terminally ill cancer patients under Federal Right to Try law.  [...]

November 8th, 2022|General|

Psychedelics and Bankruptcy with Lamar Hawkins, Esq. and Adam Nach, Esq.

Psychedelics and Bankruptcy with Lamar Hawkins, Esq. and Adam Nach, Esq. In this episode of Psychedelica Lex, I interview Lamar Hawkins and Adam Nach, two absolute giants of bankruptcy law. Our topic is the UNavailability of bankruptcy to investors and businesspeople in the non-FDA/DEA path [...]

October 28th, 2022|General|

Sep ’22 Progress Report – Creation of the Uniform Model Plant and Fungi Medicine Act is Underway!

In this installment of Psychedelic Lex, I offer a video report to the Law and Regulatory Committee of the Psychedelic Bar Association regarding our progress on creating the initial master topic "Big List" of considerations to be examined in LARC's ongoing project, creation of a Uniform [...]

September 27th, 2022|General|

Law, News, and Thoughts from the Psychedelic Frontier with Greg Lake and Ian Benoius

In this episode of Psychedelica Lex I am joined by fellow entheogen lawyers Greg Lake and Ian Benoius.  Charles Carreon was supposed to participate, so we could discuss comparisons and analysis of the various psychedelic sacramental cases pending in federal court - there are THREE [...]

September 26th, 2022|General|
Go to Top